What does RP PHARMA do?

RP PHARMA is a pharmacy in Beersel. Private Limited, started on 20 June 2025, 1 establishment.

What is the address of RP PHARMA?

The registered office of RP PHARMA is located at Groenejagersstraat 32, 1653 Beersel.

Is RP PHARMA still active?

Yes. According to the CBE (18 September 2026) RP PHARMA is active, legal situation “Normale toestand”, started on 20 June 2025.

Is RP PHARMA registered on Peppol?

Yes, RP PHARMA is registered on the Peppol network with ID 0208:1024554877.

What is the enterprise number of RP PHARMA?

The enterprise number of RP PHARMA is BE1024554877.

When was RP PHARMA founded?

RP PHARMA was founded on 20 June 2025.

Who are the directors of RP PHARMA?

According to the 2025 annual accounts, the directors of RP PHARMA are: Robin Pagliuca.

Is RP PHARMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 June 2025; 1 annual account filed (fiscal year 2025); 1 directors known from the annual account.

How much profit did RP PHARMA make in 2025?

RP PHARMA posted a profit after taxes of € 32,707 in financial year 2025.

What is the revenue of RP PHARMA?

As a small company, RP PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 43,850.

RP PHARMA (Private Limited) - Beersel - BE1024554877

Dossier RP PHARMA, printed on 18 September 2026 from databakkes.be/en/1024554877/rp-pharma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

RP PHARMA from Beersel, company number BE1024554877, closed financial year 2025 with a result of € 32,707 after tax. For that financial year RP PHARMA recorded a gross margin of € 43,850 and equity of € 33,707. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.

What it is worth Healthy

€ 33,707

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 32,707

Profit after tax over the fiscal year.

Cash in the bank

€ 20,620

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 32,707.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 57,527

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 43,815

€ 13,273 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 1,002

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 13,053

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

What happened to RP PHARMA?

What happened at RP PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 6, 2026 New annual accounts for financial year 2025: profit of € 32,707. Source: NBB ↗
Jun 20, 2025 New establishment in Beersel. KBO
Jun 20, 2025 Start of the company according to the CBE. KBO

In short

Paid € 8,428 in corporate taxes since 2025.

Original PDFs at the National Bank ↗

A new publication or filing at RP PHARMA? We notify you, reason included.

Follow RP PHARMA

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Robin Pagliuca

RP PHARMA

Behind RP PHARMA is Robin Pagliuca.

See the full network in the app

Directors

According to the 2025 annual accounts

Robin Pagliuca

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Groenejagersstraat 32

1653 Beersel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 1024.554.877
VAT number: BE 1024.554.877
Registered office: Groenejagersstraat 32, 1653 Beersel
Names & denominations: RP PHARMA
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 June 2025
Peppol: Active · Active since 15 Dec 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗